We designed the present study to examine whether or not the inhibition of acetylcholinesterase mod ulates cerebral microcirculation in hypotension and im proves brain metabolism in ischemia induced by bilateral carotid artery occlusion in hypertensive rats. Blood flow to the parietal cortex was determined by the H2 clearance method. Lactate, pyruvate, and ATP were estimated by enzymatic methods. Acetylcholinesterase inhibitor (AChEI, ENA-713), at 0.05, 0.1, or 0.5 mg/kg, was intra venously injected lO min before either hemorrhagic hy potension or cerebral ischemia. The levels of acetylcho line in the control were 29.3 ± 8. I (mean ± SD) and 39.5 ± 8. I pmoUmg in the cortex and hippocampus, respec tively, and they were significantly decreased by 15-19% after 60 min of ischemia in the vehicle-treated rats.
Cerebral blood flow is well maintained by cere bral vasodilation or vasoconstriction in response to changes in perfusion pressure (Paulson et aI., 1990; Strandgaard and Paulson, 1984) . Acetylcholine (ACh) causes significant relaxation of the arteries (Fujii et aI., 1992; Furchgott and Zawadzki, 1980; Vanhoutte, 1989) , although the role of ACh in brain during decreases in blood pressure is still under dis cussion. Recently, cholinergic deficits in the brain are considered to have a close relationship with im pairments of cognitive function (Moran et aI., 1994; Perry et aI., 1977; Wilcock et aI., 1982) , and the AChEI preserved the levels to 93-98% of the control (p < 0.05 versus vehicle). The lower limit of autoregulation was 74 ± 9% of the resting values. The administration of AChEI helped preserve blood flow and lowered the limit to 64 ± 6% (p < 0.05 versus control). After 60 min of ischemia, lactate increased 6.5-fold and ATP decreased to 64% of the control value. The administration of AChEI dose-dependently reduced the lactate level 1.9-to 3.9-fold and well preserved the A TP level to 94-97% of the con trol. The inhibition of acetylcholinesterase activity may preserve cerebral autoregulation during hypotension and protect cerebral metabolism against ischemic insult. Key Words: Acetylcholinesterase inhibitor-Cerebral autoreg ulation-Cerebral ischemia-Cerebral metabolism Hypertensive rats.
replacement of ACh has been tried as a promising therapy in patients with Alzheimer's disease (Davis and Mohs, 1982; Summers et aI., 1986) . In addition, cerebrovascular dementia, more frequent in Japan, may partly develop as a result of changes in the levels of neurotransmitters, including a decrease in ACh. We assume that activation of the cholinergic system may be protective for the cerebral microcir culation and metabolism in ischemia-induced cere bral disorders.
Acetylcholinesterase is contained in most tissues and is a remarkably effective enzyme in rapidly de stroying the cholinergic transmitter. In this study, we used a new acetylcholinesterase inhibitor (AChEI), SDZ EN A-713, (S)-N-ethyl-3-[(1-di methyl-amino) ethyl]-N-methyl-phenylcarbamate hydrogentartrate, which has potent selectivity and long-lasting effects in the brain (Enz et aI., 1989; Tanaka et aI., 1993 Tanaka et aI., , 1994 . Our purposes were to examine whether or not administration of AChE I preserves the levels of tissue ACh in the ischemic brain and modulates cerebral microcirculation dur ing hypotension (lower limits of CBF autoregula tion) in spontaneously hypertensive rats (SHR). We also investigated whether or not AChEI treatment had any favorable effects on metabolic derange ments in the ischemic brain.
MATERIALS AND METHODS
A total of 121 male SHR, 8 months old and weighing 275-290 g, were housed in the Kyushu University animal center, and fed a stock chow diet (Clea Japan, Tokyo, Japan) and tap water ad libitum. AChEI was stored as a dry powder at SOC and protected from light. Just before the study, the drug was dissolved in 0.9% saline and a 1 mUkg solution was made for intravenous injection in each rat. Control rats received an injection of vehicle (1 ml/kg of saline, i. v.).
Measurement of ACh concentration in the brain
The rats were separated into three groups: (al control rats (n = 17) for the measurement of ACh in the resting condition, (b) rats (n = 14) for the determination of ACh at 60 min of cerebral ischemia, and (c) rats for the esti mation of ACh at 60 min of cerebral ischemia after the administration of either 0.1 (n = 16) or 0.5 mg/kg (n = 17) of AChEI. The rats were anesthetized with amobarbital (100 mg/kg, i.p.), and one femoral artery and one femoral vein were cannulated for the measurement of arterial pressure and the injection of drugs, respectively. A mid line incision was made in the neck, and both common carotid arteries were carefully exposed. Either AChEI or the vehicle was injected 10 min before 60 min of supra tentorial cerebral ishcemia by bilateral carotid artery oc clusion with Heifetz's clips. Microwaves (5.0 kW) fo cused on the rat's brain were then applied for 1.5 s. The brain was quickly removed and the parietal cortex and hippocampus were dissected and frozen in a deep freezer ( -80°C). The HPLC system for the measurement of ACh concentration (LC-6A, Shimazu, Japan) consisted of an ACh analyzer column (4ooA Bioanalytical Systems, La fayette, IN, U.S.A.) equipped with an immobilized enzy matic reactor and an electrochemical detector (Fujimori and Yamamoto, 1987) .
Lower limit of CBF autoregulation
Eighteen SHR (nine rats treated with AChEI and nine control rats given the vehicle alone) were anesthetized with amobarbital (100 mg/kg, i.p.). One femoral artery and one femoral vein were cannulated for the continuous measurement of arterial pressure and administration of drugs, respectively. The H2 clearance method was used to measure CBF, as previously described (Sadoshima et ai., 1993 (Sadoshima et ai., , 1994 . The animal's head was fixed in a head holder, and one small burr hole was made on the skull 2 mm lateral to the bregma on one side. A Teflon-coated platinum electrode, 200 fLm in diameter, was stereotaxi cally placed in the parietal cortex. The depth of the elec trode tip was 1 mm from the surface of the brain. The reference electrode was an Ag-AgCI electrode placed un der the skin of the neck. The animals spontaneously breathed room air, and their body temperature was kept close to 37°C with a heat lamp.
H2 clearance curves were obtained after the inhalation of 10% H2 gas with room air, and regional CBF was cal-J Cereb Blood Flow Melab, Vol. 15, No.5, 1995 culated from the clearance curves (Aukland et ai., 1964) . At least three baseline CBF measurements were made at intervals of 10 min; then the animals received either AChEI at 0.5 mg/kg or the vehicle. At 10 min after ad ministration of the drug, the new CBF values were esti mated. We next withdrew arterial blood from the femoral arterial cannula to decrease the systemic blood pressure in a stepwise manner. The blood pressure was maintained at each level for at least 5 min during each CBF measure ment (Sadoshima et ai., 1994) . The arterial gases and pH were determined with 1304pH/Blood Gas Analyzer (In strumentation Laboratory Co. Ltd., Lexington, MA, U.S.A.) under resting conditions, at 10 min after admin istration of the drug, and just after the last measurement of CBF. The animals were then killed by injecting satu rated KCI solution into the femoral vein.
Ischemic brain metabolism
CBF to the parietal and cerebellar cortices was mea sured by the H2 clearance method. With the rats under amobarbital anesthesia (100 mg/kg, i.p.), two small burr holes were made on the skull, 2 mm lateral to the bregma and 3 mm posterior. ·and lateral to the confluence, respec tively, ,and the depth of the two electrode tips was 1 mm from the surface of the brain. After three baseline CBF measurements were obtained, eight SHR in each group received AChEI at 0.0 I, 0.1, or 0.5 mg/kg, or the vehicle alone. The new CBF values were estimated after 10 min, and then supratentorial cerebral ischemia was induced by bilateral carotid artery occlusion. The CBF values were again measured at 30 and 60 min of brain ischemia. Blood gases and pH were determined at rest and at 60 min of ischemia. The other SHR (n = 7) were sham operated to obtain control values.
At the end of the experiment, a plastic funnel was fitted into the skin of the head, and liquid nitrogen was poured over the area. The whole frozen brain was chiseled out carefully and separated grossly into the supra-and infra tentorial portions. The tissue homogenates, kept at O°C, were centrifuged and neutralized with 3N KOH at pH 5.6 ± 0.1. Lactate, pyruvate, and ATP concentrations in the homogenates were determined by a standard enzymatic method (Fuji shima et aI., 1976) .
Statistical analysis
All data are expressed as means ± SD. The significance of differences in the concentration of ACh among the groups was estimated by analysis of variance (ANOY A) using the parametric method. The levels of blood pres sure of the lower limits between the AChEI-treated and vehicle-treated groups were compared by the unpaired t test. The significance of differences among groups in CBF to the parietal or cerebellar cortex, arterial pressure, and cerebral metabolites was statistically analyzed by ANOYA followed by Scheffe's test. A value of p < 0.05 was considered significant.
RESULTS

ACh concentration in brain
The mean arterial pressure (MAP) of the animals was 187 ± 15 mm Hg, and there was little difference among the groups. The administration of AChEI did not change resting blood pressure. The concentra tion of ACh in the control rats was 39.5 ± 8.1 pmoll mg in the hippocampus, significantly greater than the 29.3 ± 8.1 in the parietal cortex. The levels of ACh in the hippocampus were also significantly higher than those in the cortex in the other groups. At 60 min of cerebral ischemia in the vehicle-treated rats, the concentration of ACh was significantly de creased to 32.0 ± 9.3 pmol/mg (p < 0.05 versus control) in the hippocampus and to 24.7 ± 6.4 (p < 0.05 ) in the cortex. The administration of either 0.1 or 0.5 mg/kg of AChEI significantly preserved the concentration: 37.1 ± 8.1 to 39.0 ± 8.4 pmol/mg (p < 0.05 versus vehicle, respectively) in the hippo campus and 27.4 ± 5.4 to 27.5 ± 7.2 in the cortex (Pig. 1).
Lower limit of CBF autoregulation
MAP was 185 ± 12 mm Hg and CBP was 49 ± 6 ml 100 g -1 min -1 under resting conditions, and they were similar among the groups. MAP and CBP remained unchanged after the administration of AChE!. The P a02 and P aco2 values were -95 and 35 mm Hg, respectively, without any differences be tween groups during the study (Table 1 ). In spite of a stepwise decrease in MAP over a wide range, CBF to the parietal cortex was maintained at a rel atively constant level and the autoregulatory func tion was well preserved. MAP was reduced further and reached a certain level, below which CBP be gan to decrease steeply, depending on the fall in blood pressure thereafter. This blood pressure level was defined as the lower limit of autoregulation where regional CBP decreased by -10% of the rest- ing value. This lower limit of autoregulation in the vehicle-treated rats was 130 ± 6 mm Hg (74 ± 4% of the resting): The administration of AChEI signifi cantly shifted this lower limit to 115 ± 6 mm Hg (64 ± 5%, P < 0.05 versus control, Pig, 2).
Tissue metabolites
Changes in MAP and CBP to the parietal or cer ebellar cortex and blood gases are depicted in Ta bles 2 and 3. The resting values of these variables were similar in all groups. MAP in all rats increased by 19-31 mm Hg soon after bilateral carotid artery occlusion and then remained elevated during 60 min of cerebral ischemia. CBP significantly decreased to -5-9 ml 100 g -I min -I in the parietal cortex at 30 and 60 min of ischemia, although the reduction in blood flow was much less or almost unchanged in the cerebellar cortex during supratentorial is chemia. Hyperventilation developed in all rats, whereas P aco2 decreased significantly to -19 mm CBF(%) Hg after 60 min of ischemia. Thus, no significant differences in the levels of MAP, regional CBF, or blood gases were observed during ischemia among the groups. Supratentorial lactate, pyruvate, the lactatel pyruvate (LIP) ratio, and ATP are illustrated in Fig.  3 . The control values for lactate, pyruvate, LIP ra tio, and ATP were 1.30 ± 0.18 mmollkg, 0.14 ± 0.03 mmollkg, and 10.3 ± 1.4 and 2.82 ± 0.09 mmol/kg, respectively (horizontal dashed lines in Fig. 3 ). Af ter 60 min of ischemia, the lactate levels in vehicle treated rats increased 6.5-fold, and ATP decreased to 64% of the control value. The LIP ratio increased to 5.5 times that of the control. The administration of AChE I before ischemia significantly and dose dependently reduced the rise in lactate levels by 1.9-to 3.9-fold (p < 0.05 to 0.01 versus vehicle). Supra tentorial ATP was well preserved to 94-97% of the control level by the administration of AChEI (p < 0.01). Similarly, the level of pyruvate tended to be well preserved, and thus the LIP ratio was signifi cantly lowered to 13-28 in SHR treated with AChEI compared with 55 ± 9 in rats treated with vehicle (p < 0.01).
DISCUSSION
ACh is a neurotransmitter of crucial significance in the physiological functioning of the brain. Isch emic insult decreases the concentration of ACh in the regions of the brain (Scremin and Jenden, 1989, 1993) . Early studies demonstrated that cortical , 1985 ; Metz, 1966) , and the cholinergic deficit is the key factor in the develop ment of Alzheimer's disease and probably cerebro vascular dementia as well (Perry et al., 1977; Wilcock et al., 1982) . Also, ACh is primarily impor tant in inducing the release of endothelium-derived relaxing factor (EDRF), which dilates vessels (Fujii et al., 1992; Furchgott and Zawadzki, 1980; Van houtte, 1989) . In this study, we examined whether or not the inhibition of acetylcholinesterase modu lates cerebral microcirculation during hypotension and ameliorates cerebral metabolism after cerebral ischemia. Our major findings were, first, that the concentration of ACh in the hippocampus was sig nificantly higher than in the cortex at rest, and ACh levels at 60 min of cerebral ischemia were signifi cantly better preserved in SHR treated with AChEI than in rats treated with vehicle; second, the lower limits of CBF autoregulation were significantly shifted to the left by -15 mm Hg after the admin istration of AChEI; and third, the increase in the concentration of lactate was dose-dependently in hibited and the levels of ATP were significantly bet ter preserved, resulting in a lowered LIP ratio after treatment with AChE!. The reduction in the degra dation of ACh after treatment with AChEI may fa vorably protect the function of the brain against ischemic insult through the preserved cerebral mi crocirculation and metabolism. The cerebral vessels are richly supplied by cholinergic as well as sympathetic and peptidergic nerves and express much greater ACh contents than most extracranial vessels (Bevan et al., 1982; Duckles, 1981; Suzuki and Hardebo, 1993) , al though the role of innervation in the regulation of CBF is still controversial. In the resting condition, even an electric stimulation of the Vth or VIIth cra nial nerves had a small or minimal effect on regional CBF (Busija and Heistad, 1981; Pinard et al., 1979) . We recently reported that the intravenous ad ministration of phenoxybenzamine, an a-blocker (Shiokawa et al., 1989) , or captopril, an angioten sin-converting enzyme inhibitor (Sadoshima et al., 1994) that decreases cerebrovascular sympathetic tone, shifts the lower limits of autoregulation to the lower levels of blood pressure with the reduction of vascular resistance in SHR. We therefore specu lated that during a decrease in arterial pressure, cholinergic activation may be beneficially involved in the regulation of CBF with vasodilation. Cholin ergic nerves might attenuate sympathetic vasocon strictor influences during hypotension or cerebral ischemia. Because the administration of AChEI did not change blood gases or resting MAP, the main tenance of CBF over a larger range of changes in blood pressure is presumably, in part, due to the effects of the drugs, such as an activation of the cholinergic nerves or an increase in the production of EDRF, and partially due to the enhanced auto regulatory capacity. We assume that the preserved concentration of ACh in the brain and the vessel walls may contribute to the effective dilation of ce rebral vessels during hemorrhagic hypotension. An estimation of changes in the regional concentration of ACh or the release of vascular relaxing factors such as nitric oxide during hypotension (ladecola et aI., 1994; Suzuki and Hardebo, 1993) should be a subject for future study.
Our model of cerebral ischemia in SHR produces constant forebrain ischemia by bilateral carotid ar tery occlusion mainly due to hemodynamic factors (Fujishima et aI., 1976) . As far as we know, the effects of the inhibition of acetylcholinesterase on the metabolic derangement in cerebral ischemia have never been studied previously. Recently, Koketsu et al. (1992) observed that the parasympa thetic denervation of pial vessels in SHR signifi cantly increased the volume of infarcted area after middle cerebral artery occlusion. In contrast, Tsu jimoto et al. (1993) reported that the intravenous injection of the same AChEI as that used in this study significantly decreased the area of brain in farction by 30% in cats with MCAo. They found, through a cranial window, well-preserved reactivity of the pial arteries and thus suggested that AChEI dilates cerebral vessels and enhances collateral circulation in the ischemic brain with an increase in the concentration of ACh. Besides vascular relaxation, EDRF and nitric oxide, a major candi-date for EDRF, released by ACh, signifi cantly inhi-bit the adhesion and aggregation of platelets (Iadecola et aI., 1994; Vanhoutte, 1989) , which may thus contribute to improved microcircualtion.
In the present study, CBF decreased to 5-9 ml 100 g-I min -I in all rats during bilateral carotid artery occlusion, and thus the level of CBF could not account for the differences in lactate or A TP among the groups. Some other factors could be pri marily involved in the amelioration of impaired me tabolism in the ischemic brain. Inhibition of acetyl cholinesterase activities prevents ischemia-induced cholinergic, dopaminergic, and serotonergic deficits (Tanaka et aI., 1993) , and ACh inhibits the central release of angiotensin II, catecholamines, and other excitatory neurotransmitters (Phillis, 1987; Unger et aI., 1988) . In previous studies, the favorable out comes from cerebral ischemia both in gerbils (Fernandez et aI., 1986 ) and stroke-prone SHR (Werner et aI., 1991) can be explained, in part, by the reduction in these excitatory neurotransmitters. Moreover, Tanaka et al. (1993) demonstrated that AChEI significantly prevented the turnover of is chemia-induced serotonin (5-HT) in the cortex and hippocampus and inhibited pyramidal cell loss caused by ischemia in the hippocampal CA 1 regions in gerbils. Similarly, the decrease in ACh by the local infusion of fluoxetine, a serotonin uptake blocker, was inhibited by the 5-HT 1 (and l3-adren ergic) antagonist propranolol, and ACh levels were either well preserved or reliably increased (Rada et aI., 1993) . There is, in fact, good evidence from studies on rats (Hoffman et aI., 1986) and in Alzhei mer's disease (Ebmeier et aI., 1992 ) that both phy sostigmine and velnacrine, an acetylcholinesterase inhibitor, increase CBF and cerebral oxygen con-sumption and glucose use, probably due to a direct effect on central cholinergic pathways. Although well preserved ATP and low lactate levels suggest the AChEI may suppress an energy demand or met abolic consumption, Scremin et al. (1993) clearly demonstrated a significant enhancement of CBFI cerebral glucose utilization in rats treated with eptastigmine. We therefore assume that inhibition of acetylcholinesterase may preserve ischemic cere bral metabolism partly by the production of ACh associated with an effect on cholinergic interneu rons.
The present results suggest that the administra tion of AChEI well preserves the concentration of tissue ACh, and thus beneficially affects the levels of CBF during acute decrease in arterial blood pres sure and thus ameliorates brain metabolism in an ischemic insult. Because the colocalization of ace tylcholinesterase is demonstrated in all structures undergoing neurofibrillary degeneration in the brain (Moran et aI., 1994) , there is a need for further stud ies on AChEI as it relates to neuronal as well as vasoactive function during the development of de mentia.
